Literature DB >> 11420333

Determination of minimum inhibitory concentrations.

J M Andrews1.   

Abstract

Minimum inhibitory concentrations (MICs) are defined as the lowest concentration of an antimicrobial that will inhibit the visible growth of a microorganism after overnight incubation, and minimum bactericidal concentrations (MBCs) as the lowest concentration of antimicrobial that will prevent the growth of an organism after subculture on to antibiotic-free media. MICs are used by diagnostic laboratories mainly to confirm resistance, but most often as a research tool to determine the in vitro activity of new antimicrobials, and data from such studies have been used to determine MIC breakpoints. MBC determinations are undertaken less frequently and their major use has been reserved for isolates from the blood of patients with endocarditis. Standardized methods for determining MICs and MBCs are described in this paper. Like all standardized procedures, the method must be adhered to and may not be adapted by the user. The method gives information on the storage of standard antibiotic powder, preparation of stock antibiotic solutions, media, preparation of inocula, incubation conditions, and reading and interpretation of results. Tables giving expected MIC ranges for control NCTC and ATCC strains are also supplied.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11420333     DOI: 10.1093/jac/48.suppl_1.5

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  750 in total

1.  Potential of 2, 2'-dipyridyl diselane as an adjunct to antibiotics to manage cadmium-induced antibiotic resistance in Salmonella enterica serovar Typhi Ty2 strain.

Authors:  Praveen Rishi; Reena Thakur; Ujjwal Jit Kaur; Harjit Singh; Kuldip K Bhasin
Journal:  J Microbiol       Date:  2017-08-05       Impact factor: 3.422

2.  Discovery of antimicrobial ribonucleotide reductase inhibitors by screening in microwell format.

Authors:  Fredrik Tholander; Britt-Marie Sjöberg
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-04       Impact factor: 11.205

3.  Prevalence of mutations within the quinolone resistance-determining region of gyrA, gyrB, parC, and parE and association with antibiotic resistance in quinolone-resistant Salmonella enterica.

Authors:  Deborah J Eaves; Luke Randall; Douglas T Gray; Antony Buckley; Martin J Woodward; Allan P White; Laura J V Piddock
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

4.  Role of topoisomerase mutations and efflux in fluoroquinolone resistance of Bacteroides fragilis clinical isolates and laboratory mutants.

Authors:  Vito Ricci; Marnie L Peterson; John C Rotschafer; Hannah Wexler; Laura J V Piddock
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

5.  Asynchronous magnetic bead rotation microviscometer for rapid, sensitive, and label-free studies of bacterial growth and drug sensitivity.

Authors:  Irene Sinn; Theodore Albertson; Paivo Kinnunen; David N Breslauer; Brandon H McNaughton; Mark A Burns; Raoul Kopelman
Journal:  Anal Chem       Date:  2012-06-01       Impact factor: 6.986

6.  The innate growth bistability and fitness landscapes of antibiotic-resistant bacteria.

Authors:  J Barrett Deris; Minsu Kim; Zhongge Zhang; Hiroyuki Okano; Rutger Hermsen; Alexander Groisman; Terence Hwa
Journal:  Science       Date:  2013-11-29       Impact factor: 47.728

7.  Methods to Inhibit Bacterial Pyomelanin Production and Determine the Corresponding Increase in Sensitivity to Oxidative Stress.

Authors:  Laura M Ketelboeter; Sonia L Bardy
Journal:  J Vis Exp       Date:  2015-08-31       Impact factor: 1.355

8.  Comparison of diversities of Escherichia coli O157 shed from a cohort of spring-born beef calves at pasture and in housing.

Authors:  Leila Vali; Michael C Pearce; Karen A Wisely; Ahmed Hamouda; Hazel I Knight; Alastair W Smith; Sebastian G B Amyes
Journal:  Appl Environ Microbiol       Date:  2005-03       Impact factor: 4.792

9.  Aspergillus fumigatus DBM 4057 biofilm formation is inhibited by chitosan, in contrast to baicalein and rhamnolipid.

Authors:  Eva Kvasničková; Vít Paulíček; Martina Paldrychová; Richard Ježdík; Olga Maťátková; Jan Masák
Journal:  World J Microbiol Biotechnol       Date:  2016-09-22       Impact factor: 3.312

10.  Exploring N-acylhydrazone derivatives against clinical resistant bacterial strains.

Authors:  Andressa C Lannes; Bruno Leal; Juliana S Novais; Viviane Lione; Georgia C T S Monteiro; André L Lourenço; Plínio C Sathler; Alessandro K Jordão; Carlos R Rodrigues; Lúcio M Cabral; Anna Claudia Cunha; Vinicius Campos; Vítor F Ferreira; Maria Cecília B V de Souza; Dilvani O Santos; Helena C Castro
Journal:  Curr Microbiol       Date:  2014-05-08       Impact factor: 2.188

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.